Disc Medicine (IRON) Enterprise Value (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.71% |
| Dec 31, 2025 | -28.45% |
| Sep 30, 2025 | 5.24% |
| Jun 30, 2025 | 6.43% |
| Mar 31, 2025 | -41.80% |
| Dec 31, 2024 | -0.52% |
| Sep 30, 2024 | 2.71% |
| Jun 30, 2024 | -46.22% |
| Mar 31, 2024 | 4.93% |
| Dec 31, 2023 | 2.73% |
| Sep 30, 2023 | 1.88% |
| Jun 30, 2023 | -59.73% |
| Mar 31, 2023 | -21.47% |
| Dec 31, 2022 | -91.36% |
| Sep 30, 2022 | 6.40% |
| Jun 30, 2022 | 8.99% |
| Mar 31, 2022 | -35.27% |
| Dec 31, 2021 | 41.19% |
| Sep 30, 2021 | 9.92% |
| Jun 30, 2021 | 9.49% |
| Mar 31, 2021 | -3,987.52% |
| Dec 31, 2020 | -213.16% |